Back
Nutanix, Inc. Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Sell
38
NTNX
Nutanix, Inc.
Last Price:
$47.58
Seasonality Move:
-6.6%
Buy
66
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$33.03
Seasonality Move:
-6.94%
Sell
38
Nutanix, Inc. (NTNX)
is a Sell
Is Nutanix, Inc. a Buy, Sell or Hold?
-
The current Nutanix, Inc. [NTNX] share price is $47.58. The Score for NTNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
NTNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $33.05. The Score for OLMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTNX Stock Price Chart
What is Nutanix, Inc.'s stock price today?
-
The Nutanix, Inc. share price today is $47.58Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTNX is experiencing selling pressure, which indicates risk of future bearish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $33.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.17 | Sell |
| Relative Strength Index (14 RSI): | 23.32 | Sell |
| Chaikin Money Flow: | -2724204 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.11 - 65.07) | Sell |
| Bollinger Bands (100): | (59.13 - 76.77) | Sell |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.91 | Buy |
| Relative Strength Index (14 RSI): | 83.22 | Buy |
| Chaikin Money Flow: | 2330353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.75 - 30.25) | Buy |
| Bollinger Bands (100): | (3.36 - 18.7) | Buy |
NTNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.42 | Buy |
| 20-day SMA: | 52.87 | Sell |
| 50-day SMA: | 62.86 | Sell |
| 200-day SMA: | 70.18 | Sell |
| 8-day EMA: | 48.12 | Sell |
| 20-day EMA: | 52.57 | Sell |
| 50-day EMA: | 60.19 | Sell |
| 200-day EMA: | 67.16 | Sell |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29 | Buy |
| 20-day SMA: | 24.82 | Buy |
| 50-day SMA: | 15.4 | Buy |
| 200-day SMA: | 7.73 | Buy |
| 8-day EMA: | 29.46 | Buy |
| 20-day EMA: | 24.88 | Buy |
| 50-day EMA: | 18.05 | Buy |
| 200-day EMA: | 10.4 | Buy |
Nutanix, Inc. Earnings Growth & NTNX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.09 per share, an increase this year of $0.52 per share, and an increase next year of $0.06 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.42 per share.
Nutanix, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||